ONB
NVO

Old National Bancorp’s Novo Nordisk NVO Stock Holding History

Old National Bancorp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
273,640
+32,362
+13% +$1.39M 0.26% 72
2026
Q1 		$8.87M Buy
241,278
+190,493
+375% +$9.03M 0.15% 124
2025
Q4 		$2.58M Buy
50,785
+38,631
+318% +$1.98M 0.04% 227
2025
Q3 		$674K Buy
12,154
+5,251
+76% +$307K 0.01% 349
2025
Q2 		$476K Buy
6,903
+3,140
+83% +$214K 0.01% 380
2025
Q1 		$261K Sell
3,763
-236
-6% -$19.5K 0.01% 436
2024
Q4 		$344K Sell
3,999
-400
-9% -$43.3K 0.01% 475
2024
Q3 		$524K Buy
4,399
+1,027
+30% +$137K 0.01% 382
2024
Q2 		$481K Sell
3,372
-276
-8% -$36.6K 0.01% 374
2024
Q1 		$468K Buy
+3,648
New +$434K 0.01% 384
2020
Q1 		– Sell
-8,354
Closed -$242K – 540
2019
Q4 		$242K Buy
8,354
+66
+0.8% +$1.83K 0.01% 485
2019
Q3 		$215K Sell
8,288
-10
-0.1% -$253 0.01% 511
2019
Q2 		$212K Sell
8,298
-546
-6% -$13.5K 0.01% 530
2019
Q1 		$231K Sell
8,844
-272
-3% -$6.68K 0.01% 503
2018
Q4 		$210K Buy
+9,116
New +$203K 0.01% 519
2016
Q4 		– Sell
-19,514
Closed -$406K – 635
2016
Q3 		$406K Sell
19,514
-5,198
-21% -$129K 0.02% 407
2016
Q2 		$665K Sell
24,712
-3,354
-12% -$92K 0.04% 284
2016
Q1 		$761K Sell
28,066
-1,012
-3% -$27.1K 0.04% 268
2015
Q4 		$845K Sell
29,078
-646
-2% -$17.9K 0.05% 247
2015
Q3 		$806K Sell
29,724
-320
-1% -$9.06K 0.05% 240
2015
Q2 		$823K Sell
30,044
-7,836
-21% -$220K 0.05% 250
2015
Q1 		$1.01M Buy
37,880
+3,054
+9% +$70.3K 0.06% 224
2014
Q4 		$737K Buy
34,826
+3,780
+12% +$84.4K 0.05% 239
2014
Q3 		$739K Buy
31,046
+3,420
+12% +$78.7K 0.05% 240
2014
Q2 		$638K Sell
27,626
-9,696
-26% -$214K 0.05% 231
2014
Q1 		$852K Sell
37,322
-3,388
-8% -$72.2K 0.08% 145
2013
Q4 		$752K Sell
40,710
-2,300
-5% -$40.1K 0.07% 120
2013
Q3 		$728K Buy
43,010
+1,780
+4% +$29.9K 0.07% 105
2013
Q2 		$639K Buy
+41,230
New +$686K 0.07% 111

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Old National Bancorp's NVO Position: Q2 2026 in Review

Old National Bancorp increased its Novo Nordisk (NVO) stake by 13% in Q2 2026, buying an estimated $1.39M and bringing the position to 273,640 shares worth $13.1M. The position accounts for 0.26% of the portfolio, ranked #72.

Old National Bancorp first reported a position in NVO in Q2 2013 and has held it in 29 quarters since. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Old National Bancorp held 273,640 shares of Novo Nordisk worth $13.1M as of Q2 2026.
  • Old National Bancorp bought 32,362 Novo Nordisk shares in Q2 2026, an estimated $1.39M.
  • Novo Nordisk made up 0.26% of Old National Bancorp's portfolio in Q2 2026, its #72 holding.
  • Old National Bancorp first reported a position in Novo Nordisk in Q2 2013 and has held it in 29 quarters since.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Old National Bancorp's 13F filing for Q2 2026, filed 15 Jul 2026.